A Personalized 14-3-3 Disease-Targeting Workflow Yields Repositioning Drug Candidates

Rare diseases typically evade the application of the standard drug discovery and development pipelines due to their understudied molecular etiology and the small market size. Herein, we report a rare disease-directed workflow that rapidly studies the molecular features of the disorder, establishes a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yonika A. Larasati, Gonzalo P. Solis, Alexey Koval, Christian Korff, Vladimir L. Katanaev
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/8/559
Tags: Add Tag
No Tags, Be the first to tag this record!